Effect of granulocyte-colony stimulation factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in rats

World Journal of Gastroenterology

Volumn 13, Issue 18, 2007, Pages 2596-2599

  Cerci, Celal ^a   Ergin, Cagri ^b   Eroglu, Erol ^a   Agalar, Canan ^c   Agalar, Faith ^c   Cerci, Sureyya ^a   Bulbul, Mahmut ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

5 fluorouracil; Bacterial translocation; Granulocyte colony stimulating factor; Peritoneal defense mechanisms

Indexed keywords

FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC ANTIMETABOLITE;

ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERICIDAL ACTIVITY; CELL COUNT; CONTROLLED STUDY; GRANULOCYTE; IMMUNE RESPONSE; LAPAROTOMY; MALE; NEUTROPHIL; NONHUMAN; PERITONEAL FLUID; PHAGOCYTOSIS; RAT; WISTAR RAT; ANIMAL; ASCITES FLUID; DRUG EFFECT; IMMUNOLOGY; LEUKOCYTE COUNT; MICROBIOLOGY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ASCITIC FLUID; BACTERIAL TRANSLOCATION; FLUOROURACIL; GRANULOCYTE COLONY-STIMULATING FACTOR; LEUKOCYTE COUNT; MALE; RATS; RATS, WISTAR;

EID: 34250689551     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i18.2596     Document Type: Article

References (33)

1. Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989; 76: 1082-1090
2. Dikken C, Sitzia J. Patients' experiences of chemotherapy: side-effects associated with 5-fluorouracil + folinic acid in the treatment of colorectal cancer. J Clin Nurs 1998; 7: 371-379
3. Katona C, Kralovanszky J, Rosta A, Pandi E, Fonyad G, Toth K, Jeney A. Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients. Oncology 1998; 55: 468-474
4. Kirmani S, Braly PS, McClay EF, Saltzstein SL, Plaxe SC, Kim S, Cates C, Howell SB. A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer. Gynecol Oncol 1994; 54: 338-344
5. Weiber S, Graf W, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. The effect of 5-fluorouracil on wound healing and collagen synthesis in left colon anastomoses. An experimental study in the rat. Eur Surg Res 1994; 26: 173-178
6. Hananel N, Gordon PH. Effect of 5-fluorouracil and leucovorin on the integrity of colonic anastomoses in the rat. Dis Colon Rectum 1995; 38: 886-890
7. Koruda MJ, Rolandelli RH. Experimental studies on the healing of colonic anastomoses. J Surg Res 1990; 48: 504-515
8. Unal AE, Cevikel MH, Ozgun H, Tunger A. Effect of granulocyte-macrophage colony stimulating factor on bacterial translocation after experimental obstructive jaundice. Eur J Surg 2001; 167: 366-370
9. Alexander JW, Boyce ST, Babcock GF, Gianotti L, Peck MD, Dunn DL, Pyles T, Childress CP, Ash SK. The process of microbial translocation. Ann Surg 1990; 212: 496-510; discussion 511-512
10. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990; 125: 403-404
11. Goris RJ, van Bebber IP, Mollen RM, Koopman JP. Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? An experimental study. Arch Surg 1991; 126: 561-565
12. Deitch EA, Winterton J, Berg R. Effect of starvation, malnutrition, and trauma on the gastrointestinal tract flora and bacterial translocation. Arch Surg 1987; 122: 1019-1024
13. MacFie J. Enteral versus parenteral nutrition: the significance of bacterial translocation and gut-barrier function. Nutrition 2000; 16: 606-611
14. Roscher R, Oettinger W, Beger HG. Bacterial microflora, endogenous endotoxin, and prostaglandins in small bowel obstruction. Am J Surg 1988; 155: 348-355
15. Metcalf D. The colony stimulating factors. Discovery, development, and clinical applications. Cancer 1990; 65: 2185-2195
16. Bergman N, Bercovici B, Sacks T. Antibacterial activity of human amniotic fluid. Am J Obstet Gynecol 1972; 114: 520-523.
17. Wilkinson PC. Neutrophil leucocyte function tests. In: Thompson RA. Techniques in clinical immunology. Oxford: Blackwell Scientific, 1977: 217-218
18. Giercksky KE. Secondary peritonitis-a major clinical problem. Scand J Gastroenterol Suppl 1984; 100: 3-5
19. Hau T. Bacteria, toxins, and the peritoneum. World J Surg 1990; 14: 167-175
20. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-411
21. Von Bultzingslowen I, Adlerberth I, Wold AE, Dahlen G, Jontell M. Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 2003; 18: 278-284
22. Deng GY, Liu YW, He GZ, Jiang ZM. Effect of dietary fiber on intestinal barrier function of 5-Fu stressed rats. Res Exp Med (Berl) 1999; 199: 111-119
23. Nomoto K, Yokokura T, Nomoto K. Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. Can J Microbiol 1992; 38: 774-778
24. Itoh N, Nishimura H, Matsuguchi T, Yajima T, Mokuno Y, Hiromatsu T, Nimura Y, Yoshikai Y. CD8 alpha-deficient mice are highly susceptible to 5-fluorouracil-induced lethality. Clin Diagn Lab Immunol 2002; 9: 550-557
25. Hirata K, Horie T. Changes in intestinal absorption of 5-fluorouracil-treated rats. Pharmacol Toxicol 1999; 85: 33-36
26. Tancrede CH, Andremont AO. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 1985; 152: 99-103
27. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991; 163: 579-583
28. Hebert JC, O'Reilly M, Gamelli RL. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 1990; 125: 1075-1078
29. Nelson S. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview. Clin Infect Dis 1994; 18 Suppl 2: S197-S204
30. Sartorelli KH, Silver GM, Gamelli RL. The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis. J Trauma 1991; 31: 523-529; discussion 529-530
31. Tuo H, Sugiyama M, Nakashima M, Abe N, Atomi Y. Effects of granulocyte colony-stimulating factor on neutrophils and inflammatory cytokines in the early stage of severe acute pancreatitis in rats. J Gastroenterol 2005; 40: 186-191
32. Pajkrt D, Manten A, van den Poll T, Tiel-van Buul MM, Jansen J, Wouter ten Cate J, van Deventer SJ. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 1997; 90: 1415-1424
33. Zhang P, Bagby GJ, Stoltz DA, Summer WR, Nelson S. Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med 1998; 26: 315-321